<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04750291</url>
  </required_header>
  <id_info>
    <org_study_id>12217</org_study_id>
    <nct_id>NCT04750291</nct_id>
  </id_info>
  <brief_title>Management of Popeye Sign With Botulinum Toxin After Bicepstenotomy</brief_title>
  <official_title>Management of Popeye Sign With Botulinum Toxin After Tenotomy of the Long Head of the Biceps Tendon: a Double-blinded Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AZ Delta</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>AZ Delta</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Double-blinded randomized controlled trial with 20 people of whom 10 will receive a placebo&#xD;
      infiltration and 10 an infiltration with botulinum toxin type A for cramping pain after&#xD;
      arthroscopic tenotomy of the long head of the biceps tendon.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Title: Management of Popeye sign with botulinum toxin after tenotomy of the long head of the&#xD;
      biceps tendon: a double-blinded randomized controlled trial Précis: Double-blinded randomized&#xD;
      controlled trial with 20 people. Randomization in 2 arms of 10 people. 3 visits will be&#xD;
      planned with a meantime of 3 months after the infiltration with botulinum toxin type A&#xD;
      (BTX-A) or placebo that will be administered at the 2nd visit.&#xD;
&#xD;
      Objective: The primary objective is to assess the effectiveness of an infiltration with&#xD;
      botulinum toxin in the biceps muscle after tenotomy of the long head of the biceps tendon for&#xD;
      pain and disability reduction.&#xD;
&#xD;
      Endpoint: The primary endpoint is a pain reduction as measured by the Visual Analogue pain&#xD;
      scale (VAS) and a reduced disability as measured by the quick DASH (Disabilities of the Arm,&#xD;
      Shoulder and Hand).&#xD;
&#xD;
      Population: 20 people who underwent an arthroscopic tenotomy of the long head of the biceps&#xD;
      tendon and are having post-operative pain in the biceps muscle.&#xD;
&#xD;
      Phase: 4&#xD;
&#xD;
      Number of Sites enrolling participants: single center study in AZ Delta Roeselare&#xD;
&#xD;
      Description of Study Agent: botulinum toxin type A (Botox®) 100 International Units by&#xD;
      intramuscular injection&#xD;
&#xD;
      Study Duration: From March 2021 till December 2022&#xD;
&#xD;
      Participant Duration: 3 months&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 9, 2021</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain change</measure>
    <time_frame>3 months</time_frame>
    <description>VAS score: Visual Analogue Scale score of 0 to 10 with 0 indicating no pain and 10 the worst pain imaginable</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Disability change</measure>
    <time_frame>3 months</time_frame>
    <description>quick DASH: Disabilities of the Arm, Shoulder and Hand 0 (no disability) to 100 (most severe disability)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Popeye Syndrome</condition>
  <arm_group>
    <arm_group_label>Botulinum toxin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Infiltration with botulinum toxin</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Infiltration with placebo or sterile saline</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Botulinum toxin type A</intervention_name>
    <description>1 infiltration in the biceps muscle with botulinum toxin (100 IU)</description>
    <arm_group_label>Botulinum toxin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>1 infiltration in the biceps muscle with placebo or sterile saline</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Provision of signed and dated informed consent form&#xD;
&#xD;
          -  Stated willingness to comply with all study procedures and availability for the&#xD;
             duration of the study&#xD;
&#xD;
          -  Have had arthroscopic tenotomy of the long head of the biceps tendon without rotator&#xD;
             cuff repair, acromioclavicular joint resection or glenoid labrum repair&#xD;
&#xD;
          -  Having bicipital pain that started after the tenotomy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  under 18 years of age&#xD;
&#xD;
          -  over 65 years of age&#xD;
&#xD;
          -  pregnancy or lactation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bert Vanmierlo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Orthopedie Roeselare AZ Delta</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pieter Van Geel, MD</last_name>
    <phone>+32474322540</phone>
    <email>pivangeel@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>AZ Delta</name>
      <address>
        <city>Roeselare</city>
        <zip>8800</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pieter Van Geel, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>February 8, 2021</study_first_submitted>
  <study_first_submitted_qc>February 8, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 11, 2021</study_first_posted>
  <last_update_submitted>October 15, 2021</last_update_submitted>
  <last_update_submitted_qc>October 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>AZ Delta</investigator_affiliation>
    <investigator_full_name>Bert VanMierlo</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>tenotomy</keyword>
  <keyword>long head of the biceps tendon</keyword>
  <keyword>botulinum toxin</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Botulinum Toxins</mesh_term>
    <mesh_term>Botulinum Toxins, Type A</mesh_term>
    <mesh_term>abobotulinumtoxinA</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

